STEREOSELECTIVE INHIBITION OF MUSCARINIC RECEPTOR SUBTYPES BY THE 8 STEREOISOMERS RELATED TO ROCIVERINE

被引:15
作者
BARBIER, P
RENZETTI, AR
TURBANTI, L
DIBUGNO, C
FORNAI, F
VAGLINI, F
MAGGIO, R
CORSINI, GU
机构
[1] UNIV PISA, SCH MED, INST PHARMACOL, I-56100 PISA, ITALY
[2] LAB GUIDOTTI SPA, I-56100 PISA, ITALY
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 290卷 / 02期
关键词
MUSCARINIC RECEPTORS; BINDING AFFINITY; STEREOSELECTIVITY; CHO (CHINESE HAMSTER OVARY) CELLS; PIRENZEPINE;
D O I
10.1016/0922-4106(95)90024-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The chemical structure corresponding to 1-hydroxy[1,1'-bicyclohexyl]-2-carboxylic acid 2-(diethylamino)-1-methylethyl ester has the classical profile of ester-type antimuscarinic drugs. The presence of three chiral carbons leads to eight stereoisomers and the substitutions on the cyclohexyl ring generate cis-isomers (1, named rociverine) and trans-isomers (2). The aim of this study was to determine the binding pattern of the eight stereoisomers and two derived compounds, (1S,2S)-1-hydroxy[1,1'-bicyclohexyl]-2-carboxylic acid 2-(dimethylamino)-1-ethyl ester (3) and (1S,2S)-1-hydroxy[1,1'-bicyclohexyl]-2-carboxylic acid (S)-2-(diethylamino)-1-methylethyl ester methyl iodide (4), at the five cloned muscarinic receptors stably expressed in chinese hamster ovary cells, in order to define how stereochemical modifications could affect the affinity. Our data showed that cis-stereoisomers exhibited higher variations in affinity than trans-stereoisomers. Among the cis-stereoisomers, those with the (1R,2R) configuration showed considerably higher affinities (up to 240-fold) than those with the (1S,2S) configuration. The (1S,2S) configuration was important for binding selectivity; this was confirmed also by the use of the two additional compounds.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 39 条
  • [21] KURTENBACH E, 1990, J BIOL CHEM, V265, P13702
  • [22] LAI J, 1992, J PHARMACOL EXP THER, V262, P173
  • [23] STEREOSELECTIVITY AT MUSCARINIC RECEPTOR SUBTYPES - OBSERVATIONS WITH THE ENANTIOMERS OF PHENGLUTARIMIDE
    LAMBRECHT, G
    FEIFEL, R
    MUTSCHLER, E
    [J]. CHIRALITY, 1989, 1 (02) : 170 - 173
  • [24] STEREOSELECTIVITY OF THE ENANTIOMERS OF TRIHEXYPHENIDYL AND ITS METHIODIDE AT MUSCARINIC RECEPTOR SUBTYPES
    LAMBRECHT, G
    FEIFEL, R
    MOSER, U
    AASEN, AJ
    WAELBROECK, M
    CHRISTOPHE, J
    MUTSCHLER, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (1-2) : 167 - 170
  • [25] LAMBRECHT G, 1989, TRENDS PHARMACOL SCI, P60
  • [26] LAMBRECHT G, 1986, INNOVATIVE APPROACHE, P353
  • [27] LAMBRECHT G, 1989, TRENDS MED CHEM 88, P265
  • [28] LEVEY AI, 1991, J NEUROSCI, V11, P3218
  • [29] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [30] BINDING PROFILE OF THE SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST TRIPITRAMINE
    MAGGIO, R
    BARBIER, P
    BOLOGNESI, ML
    MINARINI, A
    TEDESCHI, D
    MELCHIORRE, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (03): : 459 - 462